Praxair (NYSE:PX) with annual revenues of $8.3 billion and operations in 40 countries, is one of the world’s largest fully integrated industrial gas and engineering companies. In addition to being a leading global supplier of high quality industrial, medical and specialty gases, Praxair's targeted technologies help give chemical and pharmaceutical companies an edge in today's competitive markets. As synthesis reactions become more complex, chemical and API producers are requiring refrigeration systems that provide ultra-low temperatures, robust performance and increased reactor cooling reliability. Praxair's direct and indirect cooling technologies provide the benefits of liquid nitrogen's refrigeration capabilities without the risk of freezing. This results in broader operating ranges and improved process reliability when compared to alternative mechanical or less sophisticated cryogenic cooling systems. The net benefit is enhanced process control and protection of your valued product.Praxair's VOC recovery technologies provide chemical and API-producing facilities with safe and reliable systems to reduce emissions and recover value from their gaseous effluent streams. The cryogenic condensation process uses liquid nitrogen to cool the effluent gas to very low temperatures in order to condense and recover valuable products and solvents. Since the cold nitrogen never comes into direct contact with the effluent stream, pure nitrogen gas is also available to be used elsewhere in the facility. Whether you are starting a new plant or have need to expand the treatment capabilities of an existing site, Praxair's VOC recovery systems are cost-effective alternatives to combustion-based treatment options.Whether you require high performance reactor/fluid cooling, advanced air or water related environmental controls or efficient inerting, stripping or sparging, Praxair's experienced technology teams can help you succeed. Please call us at 1-800-PRAXAIR.